Deerfield Management Company — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
HealthtechMaple Grove, US
Michael Brenzel(Executive Officer)Paul Buckman(Executive Officer)Kent Lind(Executive Officer)John Feriancek(Executive Officer)Paul Hindrichs(Executive Officer)David Blue(Executive Officer)
Board seatAndrew ElBardissi· per SEC Form D · $5M raise · filed Jan 2019
Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.
BiotechBedford, US
Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)
BoardSteven Gillis(Director)Arthur Tzianabos(Executive Officer, Director)Kush Parmar(Director)inRichard Gregory(Director)
Co-investors5AM VenturesARCH Venture PartnersOUP (Osage University Partners)AlexandriaHBM Healthcare InvestmentsMaverick Ventures+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.